Published in
Elsevier, The Lancet Infectious Diseases, 9(19), p. 988-1000, 2019
DOI: 10.1016/s1473-3099(19)30163-x
Links
Tools
Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis
Journal article published in 2019 by
Alemnew F. Dagnew 
,
Osman Ilhan,
Won-Sik Lee,
Dariusz Woszczyk,
Jae-Yong Kwak,
Stella Bowcock ,
Sang Kyun Sohn,
Gabriela Rodriguez Macías,
Tzeon-Jye Chiou,
Dimas Quiel,
Mickael Aoun,
Maria Belen Navarro Matilla,
Javier de la Serna,
Samuel Milliken,
John Murphy
and other authors.
,
Osman Ilhan,
Won-Sik Lee,
Dariusz Woszczyk,
Jae-Yong Kwak,
Stella Bowcock ,
Sang Kyun Sohn,
Gabriela Rodriguez Macías,
Tzeon-Jye Chiou,
Dimas Quiel,
Mickael Aoun,
Maria Belen Navarro Matilla,
Javier de la Serna,
Samuel Milliken,
John Murphy
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 